LIN; Songnian

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIN; Songnian.The latest application filed is for "glucose-responsive insulin conjugates".

Company Profile

11.29.50

LIN; Songnian - Kenilworth NJ US
Lin; Songnian - Holmdel NJ
Lin; Songnian - Monroe NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucose-responsive Insulin Conjugates App 20220273770 - Feng; Danqing ; et al.	2022-09-01
Conjugate based systems for controlled insulin delivery Grant 11,413,352 - Moyes , et al. August 16, 2	2022-08-16
Glucose-responsive Insulin Conjugates App 20220233647 - Feng; Danqing ; et al.	2022-07-28
HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER App 20210340207 - Abrahams; Cristina ; et al.	2021-11-04
Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor Grant 11,077,092 - Guan , et al. August 3, 2	2021-08-03
Insulin dimer-incretin conjugates Grant 11,058,775 - Palani , et al. July 13, 2	2021-07-13
Conjugate Based Systems For Controlled Insulin Delivery App 20210198339 - Yan; Lin ; et al.	2021-07-01
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes Grant 11,041,009 - Feng , et al. June 22, 2	2021-06-22
Conjugate Based Systems For Controlled Insulin Delivery App 20210177981 - Yan; Lin ; et al.	2021-06-17
Azide Insulin Analogues App 20210163568 - Boga; Sobhana Babu ; et al.	2021-06-03
Insulin receptor partial agonists and GLP-1 analogues Grant 10,953,076 - Mu , et al. March 23, 2	2021-03-23
Tyrosine-specific Functionalized Insulin And Insulin Analogs App 20210002345 - Kekec; Ahmet ; et al.	2021-01-07
Insulin receptor partial agonists Grant 10,800,827 - Lin , et al. October 13, 2	2020-10-13
Insulin receptor partial agonists Grant 10,689,430 - Lin , et al.	2020-06-23
Glucose Responsive Insulin Comprising A Tri-valent Sugar Cluster For Treatment Of Diabetes App 20200087375 - Feng; Danqing ; et al.	2020-03-19
Insulin Dimer-incretin Conjugates App 20190192675 - PALANI; Anandan ; et al.	2019-06-27
Insulin-incretin Conjugates App 20190175744 - Palani; Anandan ; et al.	2019-06-13
Insulin Receptor Partial Agonists App 20190177393 - Lin; Songnian ; et al.	2019-06-13
Insulin Receptor Partial Agonists And Glp-1 Analogues App 20190142906 - Mu; Yingjun ; et al.	2019-05-16
Insulin Receptor Partial Agonists App 20190092833 - Lin; Songnian ; et al.	2019-03-28
Insulin receptor partial agonists Grant 10,183,981 - Lin , et al. Ja	2019-01-22
Insulin Receptor Partial Agonists App 20180291078 - Lin; Songnian ; et al.	2018-10-11
Isoquinoline derivatives as MGAT2 inhibitors Grant 10,065,945 - Berger , et al. September 4, 2	2018-09-04
Glucose-responsive Insulin Conjugates App 20180110863 - Feng; Danqing ; et al.	2018-04-26
Glucose-responsive insulin conjugates Grant 9,889,205 - Lin , et al. February 13, 2	2018-02-13
Glucose-responsive insulin conjugates Grant 9,884,125 - Lin , et al. February 6, 2	2018-02-06
Isoquinoline Derivatives As Mgat2 Inhibitors App 20180009796 - Berger; Richard ; et al.	2018-01-11
Insulin Receptor Partial Agonists App 20170355743 - Lin; Songnian ; et al.	2017-12-14
Method For Screening Drug-saccharide Conjugates App 20170254798 - Mu; Yingjun ; et al.	2017-09-07
Method For Screening Drug-saccharide Conjugates App 20170248580 - Mu; Yingjun ; et al.	2017-08-31
Methods Of Treating Diabetes By Administering A Glucagon Receptor Antagonist In Combination With A Cholesterol Absorption Inhibitor App 20170216250 - Guan; Hong-Ping ; et al.	2017-08-03
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 9,649,294 - Lin , et al. May 16, 2	2017-05-16
Insulin Receptor Partial Agonists App 20170107268 - Lin; Songnian ; et al.	2017-04-20
2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment Grant 9,527,838 - Lin , et al. December 27, 2	2016-12-27
Glucose-responsive Insulin Conjugates App 20160303244 - Lin; Songnian ; et al.	2016-10-20
Glucokinase activator compounds, compositions containing such compounds, and methods of treatment Grant 9,453,038 - Lin , et al. September 27, 2	2016-09-27
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20160250184 - LIN; SONGNIAN ; et al.	2016-09-01
Glucose-responsive Insulin Conjugates App 20160251407 - Lin; Songnian ; et al.	2016-09-01
Glucose-responsive insulin conjugates Grant 9,427,475 - Lin , et al. August 30, 2	2016-08-30
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 9,359,339 - Lin , et al. June 7, 2	2016-06-07
Novel Glucokinase Activator Compounds, Compositions Containing Such Compounds, And Methods Of Treatment App 20150336991 - Lin; Songnian ; et al.	2015-11-26
Novel 2-pyridinecarboxamide Derivatives, Compositions Containing Such Compounds, And Methods Of Treatment App 20150336946 - Lin; Songnian ; et al.	2015-11-26
Methods Of Treating Diabetes By Administering A Glucagon Receptor Antagonist In Combination With A Cholesterol Absorption Inhibitor App 20150320724 - Guan; Hong-Ping ; et al.	2015-11-12
Glucose-responsive Insulin Conjugates App 20150105317 - Lin; Songnian ; et al.	2015-04-16
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20150018399 - LIN; SONGNIAN ; et al.	2015-01-15
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,809,579 - Kats-Kagan , et al. August 19, 2	2014-08-19
Glucagon receptor antagonist compounds Grant 8,445,538 - Lin , et al. May 21, 2	2013-05-21
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,436,015 - Lin , et al. May 7, 2	2013-05-07
Antidiabetic tricyclic compounds Grant 8,399,507 - Liang , et al. March 19, 2	2013-03-19
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,324,384 - Lin , et al. December 4, 2	2012-12-04
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,318,667 - Lin , et al. November 27, 2	2012-11-27
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110312911 - Kats-Kagan; Roman ; et al.	2011-12-22
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110306624 - Lin; Songnian ; et al.	2011-12-15
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110301082 - Lin; Songnian ; et al.	2011-12-08
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110281795 - Lin; Songnian ; et al.	2011-11-17
Antidiabetic bicyclic compounds Grant 8,039,484 - Ge , et al. October 18, 2	2011-10-18
Glucagon Receptor Antagonist Compounds App 20110251248 - Lin; Songnian ; et al.	2011-10-13
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110172256 - Lin; Songnian ; et al.	2011-07-14
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity App 20100234409 - Yang; Lihu ; et al.	2010-09-16
Antidiabetic Tricyclic Compounds App 20100216694 - Liang; Gui-Bai ; et al.	2010-08-26
Antidiabetic bicyclic compounds Grant 7,759,493 - Ge , et al. July 20, 2	2010-07-20
Antidiabetic Bicyclic Compounds App 20100105725 - Ge; Min ; et al.	2010-04-29
Antidiabetic Bicyclic Compounds App 20090312303 - Ge; Min ; et al.	2009-12-17
Antidiabetic bicyclic compounds Grant 7,442,808 - Ge , et al. October 28, 2	2008-10-28
Antidiabetic Bicyclic Compounds App 20080090865 - Ge; Min ; et al.	2008-04-17
Antidiabetic bicyclic compounds App 20070265332 - Ge; Min ; et al.	2007-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.